Oct 27
Researchers at Duke University School of Medicine have been selected to lead two inter-institution team grants totaling $18 million to investigate Parkinson’s disease. The awards from the Aligning Science Across Parkinson’s (ASAP) initiative position Duke as a national leader in understanding the origins and development of this devastating movement disorder. Duke’s coordinating lead investigators for …
May 07
Members of the Duke Neurology Department advanced the fields of clinical, translational, and basic neuroscience this April with 14 new peer-reviewed studies. Nicole Calakos, MD, PhD, was the senior author of a new study in Science that expands our understanding of the integrated stress response in the brain and how it influences learning and memory. …
Jan 21
The Duke University and the University of North Carolina Alzheimer’s Disease Research Collaborative (Duke/UNC ADRC) brings together leading researchers in Alzheimer’s disease and related dementias across two major research institutions. Together, the Duke/UNC ADRC aims to catalyze and support research, innovations in clinical care and academic work force development (with North Carolina Central University, East Carolina …
Oct 01
This September, members of the Duke Neurology Department contributed to 26 new studies, advancing our knowledge of neuroscience at the subcellular, national, and global levels. Ornit Chiba-Falek, PhD, and Laurie Sanders, PhD, lead studies that answered questions about the genetic origins of Parkinson’s disease and its connection to some forms of breast cancer. Meanwhile, Ying …
Jul 16
New research from the Duke Neurology Department advanced our understanding of neurological diseases and patient care at the basic science, translational, and clinical levels. Among other topics, our faculty, trainees, and staff found evidence for virtual reality’s potential in neurorehabilitation, tested a wearable device that can help better identify seizures, and reviewed how our understanding …
Apr 23
As a graduate student, Matthew Scaglione, PhD, became interested in how the body made and destroyed proteins–and how these processes could go wrong in neurodegenerative disease. Now, as an assistant professor at Duke, his research straddles the intersections between neurology, molecular genetics, and microbiology to better understand how we might be able to develop treatments …
Apr 13
What do a genetic analysis of the intersecting pathways between Alzheimer’s disease and depression, a national prize-winning essay examining the ethics of unionization for physicians, and a systematic review of the literature surrounding a new potential form of therapy for stroke recovery have in common? They’re all subjects of peer-reviewed journal articles written or co-written …
Jan 13
Members of the Duke Department of Neurology contributed to nine studies in peer-reviewed journals published in December 2019. In the fields of neurodegeneration and neuromuscular disease, our faculty found potential new avenues for therapies for spinocerebellar ataxia type 7 (SCA7) and myasthenia gravis. Other studies by our faculty and housestaff answered important questions about how …
Nov 21
Alexandra Angelova was 16 when she began experiencing blurry vision and occasional dizzy spells. Instead of going away, her symptoms gradually grew worse. Now nearly a decade later, with her vision at one percent of its original strength and with balance problems that prevent standing or walking unassisted, these symptoms inform every aspect of her …
Oct 30
By Angela Spivey / Photos by Alex Boerner More than 10 million people worldwide—about 1 percent of people over age 60—live with Parkinson’s disease. There are treatments that can help control symptoms, but there is no cure. The hallmark of the disease is the death of certain brain cells—neurons that produce dopamine. Most Parkinson’s researchers …
Recent Comments